Brind.

Regentis Biomaterials Ltd., based in Herzliya, is undergoing institutional investment disclosures and received an analyst rating upgrade.

3 reports, 1 independent Updated Aug 1

Gone quiet

Reports: 3
Developments: 1
Repetition: 67%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Regentis Biomaterials Ltd., based in Herzliya, is undergoing institutional investment disclosures and received an analyst rating upgrade.

Who's involved

What this event is mainly about

ThinkEquity SEC

Keep exploring

The entities involved

ThinkEquity
US investment banking firm

Nothing else this week.
SEC
Slovak company
- DHS, DOJ, and SEC formed a joint initiative to establish a Trade Fraud Task Force, setting standards for compliance.Mon 17:57
- The Fidelis Partnership is incorporating in Bermuda and filing for an initial public offering on the NYSE, with principal offices in London and a main office in Dublin.Mon 17:12

Related events

Analyst upgraded Ironwood Pharmaceuticals to 'hold' rating, concurrent with insider selling disclosures filed with the SEC.Sat 10:54

Coverage

Newest first; wire copies grouped

Jul 13dailypolitical.com
Jun 18dailypolitical.com

1 more outlet ran the same wire story

Aug 1themarketsdaily.com